Shared Regulatory Circuits in Pregnancy and Cancer

One of the more intriguing patterns in biology is that processes for normal development often resemble those that appear in disease. Few examples illustrate this better than the similarity between trophoblast invasion during pregnancy and the early stages of tumor growth.

In both situations, cells penetrate surrounding tissue, remodel blood vessels, and establish themselves within an environment that tolerates their presence rather than destroying them. The mechanisms that allow this to occur remain incompletely understood. Increasing evidence suggests that deubiquitinases (DUBs), enzymes that remove ubiquitin from proteins and thereby regulate signaling thresholds, may play an important role in stabilizing this permissive state.

This raises a provocative possibility: the regulatory machinery that enables the maternal–fetal interface to tolerate trophoblast invasion may share features with the mechanisms tumors exploit to evade immune detection.

During early pregnancy, decidual natural killer cells (dNK) become the dominant immune cell population in the uterus. Rather than behaving as cytotoxic killers, these cells adopt a distinct phenotype that supports; angiogenesis, spiral artery remodeling, trophoblast invasion.

The density of NK cells in the decidua is striking, often representing 50–70% of immune cells in early pregnancy. Instead of attacking invading trophoblasts, these NK cells participate in building the placenta and converting maternal spiral arteries into vessels capable of supporting fetal circulation.

Maintaining such a high density of NK cells without triggering immune destruction requires a carefully tuned balance between activation signals and inhibitory regulatory pathways. One of the central signals controlling NK cells in both peripheral tissues and the uterus is IL-15. In the decidua, IL-15 produced by stromal cells supports the recruitment, proliferation and survival of NK cells.

Recent work has identified YTHDF2, an m⁶A RNA-binding protein, as a key downstream regulator of this process. In NK cells: IL-15 → STAT5 → YTHDF2 → NK-cell homeostasis. YTHDF2 regulates the stability of specific mRNAs that determine NK survival, proliferation and maturation. Through selective RNA decay, YTHDF2 effectively tunes the functional state of NK cells.

A p53 regulatory layer likely intersects with this system. p53 is best known as a tumor suppressor that responds to DNA damage and cellular stress by regulating transcriptional programs controlling cell cycle arrest and apoptosis. But, p53 also plays an important role in immune signaling and communication between stressed cells and the immune system.

For example, p53 activation can influence immune surveillance by inducing chemokines and inflammatory mediators that recruit immune cells, including NK cells. This places p53 upstream of many of the stress-response pathways that determine whether an NK cell should eliminate a target.

p53, and repeat RNA constitute an innate sensing axis through a recently uncovered layer of regulation involving endogenous repetitive elements and innate immune sensing. Wild-type p53 helps suppress the activity of transposable elements such as LINE-1 and other repeat sequences. Loss or mutation of p53 can lead to derepression of these elements and the production of immunogenic nucleic acids. Many repetitive elements, including Alu sequences, can form double-stranded RNAs that activate innate immune sensors such as RIG-I and MDA5. Through these pathways, endogenous RNA molecules can mimic viral infection and activate interferon responses.

p53 also intersects with the cGAS–STING pathway, another major nucleic-acid sensing system. Wild-type p53 can promote activation of STING signaling by enabling cytosolic DNA accumulation through degradation of the nuclease TREX1. In contrast, mutant p53 can suppress STING signaling, helping tumors evade immune detection. Together these findings suggest that p53 may influence immune surveillance not only through classical stress pathways, but also through control of endogenous nucleic-acid signaling systems.

While RNA regulation shapes the NK-cell transcriptome, a second regulatory layer operates through ubiquitin signaling. Many proteins involved in immune activation are controlled by ubiquitination. Deubiquitinases (DUBs) reverse this process, stabilizing proteins or suppressing signaling cascades depending on the target. One DUB that has recently drawn attention is USP13 that has been shown to regulate several pathways central to immune signaling and cellular stress responses, including STING-dependent innate immune activation. Network analysis in prostate cancer datasets also show a strong interaction between USP13 and the RNA regulator YTHDF2, linking ubiquitin signaling to the RNA regulatory machinery governing NK cells. 

Interestingly, the relationship between NK cells and invasive cells is not unique to pregnancy. Studies show that NK cells often accumulate in tissues surrounding early tumors, particularly during the earliest stages of transformation. In many cancers, NK cells are present in peritumoral tissue, but become functionally suppressed or excluded as tumors progress. This pattern suggests that the immune system initially recognizes abnormal cells but may later be restrained by tumor-driven immunoregulatory mechanisms. The result is a paradox: NK cells are present but ineffective.

Taken together, these observations suggest a regulatory architecture that could stabilize environments where invasion must occur without triggering destructive immunity.

In such a system:

1. Cellular stress signals activate p53 and generate stress-response transcripts.

2. Endogenous repeat RNAs may activate innate immune sensing pathways such as RIG-I, MDA5 and STING.

3. Cytokine signaling such as IL-15 supports NK-cell expansion and survival.

4. RNA-level regulation via YTHDF2 tunes NK-cell gene expression and maturation.

5. Deubiquitinases such as USP13 modulate innate immune signaling intensity and prevent excessive inflammatory activation.

The combined effect could be a high-NK-density but low-cytotoxic environment capable of supporting tissue remodeling and vascular development. In pregnancy, this environment enables trophoblast cells to invade maternal tissue and establish the placenta. Tumors may exploit the same architecture

Early tumors face a challenge similar to that encountered by trophoblasts: they must expand and invade tissue while avoiding immune elimination.

Many tumors exhibit features reminiscent of the decidual microenvironment, including; suppressed innate immune signaling, dysfunctional or tolerized NK cells, enhanced angiogenesis and extensive tissue remodeling.  If DUBs such as USP13 help establish these permissive states, tumors could potentially co-opt the same regulatory circuits that operate at the maternal–fetal interface.

In this view, tumors may hijack a developmental program that normally allows pregnancy to proceed successfully. 

The decidua represents one of the most extreme natural examples of immune tolerance in mammals. Understanding how this system maintains large NK-cell populations without triggering inflammation could reveal new strategies for controlling immune responses in other contexts.

If deubiquitinase signaling and p53-mediated nucleic-acid sensing help stabilize this balance, they may represent a broader biological principle; the same regulatory networks that enable successful pregnancy may also be exploited by tumors to evade immune detection.

Recent studies showing that rye-derived alkylresorcinols activate SIRT3-mediated autophagy and restore mitochondrial function suggest that metabolic stress regulation may sit upstream of the inflammatory and immune circuits that govern both trophoblast implantation and tumor invasion.

Uncovering these shared mechanisms could deepen our understanding of both reproductive biology and cancer immunology, and potentially reveal new therapeutic strategies in the process.

Natural Killers, Mitochondria, p53, and Parkinson’s

The emerging landscape of neuro-immune communication reveals that the traditional boundaries between immune sentinel function and neuronal integrity are far less distinct than once imagined. One useful framework for understanding Parkinson’s disease (PD) begins with environmental triggers, particularly persistent toxins such as dioxins and related xenobiotics. These compounds can initiate a molecular cascade: toxin exposure → mitochondrial dysfunction → oxidative stress → p53 activation → neuronal apoptosis. Embedded within this cascade is a regulatory layer involving bHLH-PAS transcription factor complexes, including AHR–ARNT and HIF1A–ARNT, which bind promoter elements containing GCGTG/GCTGTG motifs and coordinate cellular responses to environmental and metabolic stress. The toxicological effects of dioxins are largely mediated through activation of the aryl hydrocarbon receptor (AHR) transcription pathway (see research overview: https://espace.library.uq.edu.au/view/UQ%3A382961).

Within this molecular framework lies another equally compelling axis: the role of Natural Killer (NK) cells as innate effectors at the neuro-immune interface. These cells, capable of homing to inflamed neural tissue and scavenging pathological aggregates such as α-synuclein, emerge not as passive bystanders but as regulators of disease progression. Experimental work has demonstrated that NK cells can internalize and degrade extracellular α-synuclein aggregates, and that NK-cell depletion significantly worsens synuclein pathology in mouse models of Parkinson’s disease (Nature Communications research summary: https://pmc.ncbi.nlm.nih.gov/articles/PMC6983411/).

NK cells are uniquely positioned to influence neural landscapes because they bridge innate immunity with neuronal signaling. They communicate not only through cytotoxic mechanisms but also through synapse-like contacts and cytokine signaling that mirror the bi-directional dialogue inherent to neural circuits. Reviews of immune mechanisms in PD increasingly highlight NK cells as modulators of neuroinflammation and α-synuclein pathology (Frontiers in Aging Neuroscience review: https://www.frontiersin.org/articles/10.3389/fnagi.2022.890816/full).

This neuro-immune unit invites us to see PD not solely as a problem of intrinsic neuronal failure, but as a disturbance in the regulatory network connecting environmental sensing, immune surveillance, and neural homeostasis.

At the center of this network sits the aryl hydrocarbon receptor (AHR), a toxin-sensing transcription factor activated by environmental pollutants such as dioxins and polycyclic aromatic hydrocarbons. Once activated, AHR forms a heterodimer with ARNT and binds regulatory DNA elements containing GCGTG-type motifs, initiating transcriptional programs that reshape metabolism and stress responses. A parallel sensing system operates through HIF1A, another bHLH-PAS transcription factor that binds related RCGTG/GCGTG promoter motifs during mitochondrial dysfunction or oxygen imbalance. Importantly, studies show substantial crosstalk between AHR and HIF signaling pathways, allowing environmental toxins and metabolic stress to converge on shared transcriptional targets (Life Science Alliance research: https://pmc.ncbi.nlm.nih.gov/articles/PMC9896012/).

For neurons—particularly the metabolically fragile dopaminergic neurons of the substantia nigra—persistent activation of toxin-responsive pathways can have profound consequences. Xenobiotic metabolism generates oxidative stress and mitochondrial injury, activating p53, the master regulator of cellular stress responses. As explored in earlier Codondex work on mitochondrial signaling and p53-regulated RNA networks, mitochondrial dysfunction and p53 activation are tightly intertwined components of cellular stress adaptation.

But these pathways do not operate only within neurons. p53 signaling and mitochondrial health also influence immune cells, including NK cells. NK cells rely heavily on mitochondrial metabolism for effective surveillance, cytokine production, and cytotoxic function. When toxin exposure disrupts mitochondrial integrity systemically, it may impair the very immune cells responsible for clearing damaged neurons and pathological protein aggregates.

Recent studies confirm that NK cells are present in brains affected by PD and may influence disease course, scavenging α-synuclein aggregates and modulating neuroinflammation. Experimental depletion of NK cells exacerbates synuclein pathology and inflammatory responses in PD models (Cellular & Molecular Immunology study: https://www.nature.com/articles/s12276-020-00505-7).

Viewed through the lens of toxin vulnerability, the cascade becomes clearer:

Environmental neurotoxicants such as dioxins activate AHR, engaging GCGTG-containing promoter elements and reshaping transcriptional programs governing metabolism and inflammation. Toxin-induced mitochondrial dysfunction stabilizes HIF1A, reinforcing stress-adaptation pathways.

In neurons, these converging signals activate p53-dependent apoptotic programs, leading to dopaminergic neuron loss.

In immune cells, including NK cells, mitochondrial impairment and p53 signaling influence metabolic fitness and cytokine output.

Thus the integrity of mitochondrial networks becomes a common currency between neuronal survival and immune effector competence. Rather than viewing PD strictly as a neuronal degenerative disorder, integrating environmental toxin sensing with immune biology suggests a broader model in which:

Environmental pollutants such as dioxins and related xenobiotics prime cellular stress responses through AHR-mediated transcription. These signals converge with HIF1A and p53 pathways, amplifying mitochondrial dysfunction.

NK cells and other innate lymphocytes respond to neuronal danger cues and help clear pathological aggregates, but their effectiveness is constrained when toxin exposure disrupts systemic mitochondrial health. In this perspective, Parkinson’s disease emerges as a neuro-immune network disorder shaped by environmental vulnerability, where toxin sensing, mitochondrial integrity, transcriptional stress responses, and immune surveillance converge.